Study of LCE2C: Unlocking Its Potential as A Drug Target (G353140)

Target Name: LCE2C

NCBI ID: G353140

LCE2C

Study of LCE2C: Unlocking Its Potential as A Drug Target

LCE2C (Leucine-conjugated protein 2C) is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and gastrointestinal tract. It is a member of the leucine-conjugated protein family, which includes a variety of proteins that are involved in various cellular processes, including signaling, DNA replication, and response to stress.

One of the unique features of LCE2C is its ability to form a monomeric species, which means that it can exist as a single protein molecule in the cell. This is important for its function as a drug target, as researchers can use small interfering RNA (siRNA) to knockdown the expression of LCE2C and study its effects on cellular processes.

In addition to its potential as a drug target, LCE2C is also a potential biomarker for various diseases. For example, LCE2C has been shown to be involved in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Additionally, LCE2C has been associated with various cardiovascular diseases, including heart failure and hypertension.

One of the challenges in studying LCE2C as a drug target is its complex structure. LCE2C is a member of the leucine-conjugated protein family, which includes a variety of proteins with different lengths and modifications. This makes it difficult to predict the binding sites of small molecules and identify potential drug targets.

To overcome this challenge, researchers have used a variety of techniques to study the structure and function of LCE2C. One approach is to use site-directed mutagenesis to create new variants of LCE2C with different lengths and modifications. These mutations can then be tested for their ability to interact with small molecules and identify potential drug targets.

Another approach is to use biochemical assays to study the interactions between LCE2C and small molecules. This can include studies of the effects of small molecules on LCE2C stability and activity, as well as the effects of LCE2C on the activity of small molecules.

In addition to these approaches, researchers have also used computational tools to study the structure and function of LCE2C. This includes studies of the three-dimensional structure of LCE2C using techniques such as nuclear magnetic resonance (NMR) and X-ray crystallography.

Overall, LCE2C is a protein that has significant potential as a drug target and biomarker. Its unique ability to form a monomeric species and its involvement in various cellular processes make it an attractive target for small molecules. Additionally, its complex structure and the challenges associated with studying it make it an important area of research.

Protein Name: Late Cornified Envelope 2C

Functions: Precursors of the cornified envelope of the stratum

The "LCE2C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LCE2C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets